“…Of these, the carboxyl-terminal 19-kDa fragment, which contains two epidermal growth factor (EGF)-like domains, remains on the surface of the invading merozoite and is carried into the newly invaded erythrocytes (5,7). Antibodies directed against this region are capable of interfering with invasion (5,8,14), animals actively immunized with this region are protected against subsequent challenge (12,23,24), and naturally acquired antibodies to this region are associated with clinical immunity to P. falciparum malaria (19).…”